be induced by 1,25 D 3 in SCC25 human epithelial tumor cells (derived from a tongue squamous cell carcinoma) (8) . It has also been demonstrated that the topical application of 1,25 D 3 leads to the induction of TSLP expression in mouse epidermal keratinocytes (9). However, whether vitamin D affects the expression of TSLP in human bronchial epithelial (HBE) cells remains unresolved.
Introduction
Emerging evidence indicates that vitamin D insufficiency is associated with several lung diseases, including asthma and chronic obstructive pulmonary disease (COPD), which may be associated with impaired pulmonary function, and the increased incidence of inflammation and infection (1, 2) . The exact underlying mechanisms are unknown; however, vitamin D appears to affect the function of inflammatory and structural cells, including lymphocytes, dendritic cells, monocytes and epithelial cells (1, 3, 4) . 1α-hydroxylase is responsible for the final and ratelimiting step in the synthesis of active 1,25-dihydroxyvitamin D 3 (1,25 D 3 ) from the circulating or storage form, 25-hydroxyvitamin D 3 (25 D 3 ) (5). In 2008, Hansdottir et al reported that airway epithelial cells express 1α-hydroxylase and are able to convert vitamin D from an inactive form into an active one, and that vitamin D affects the expression of vitamin D-driven genes that play a major role in host defense (4) . The expression of 1α-hydroxylase in airway epithelial cells suggests a broader role of vitamin D in respiratory diseases.
Airway epithelial cells are not only physical barriers to invaders, but also produce cytokines, such as thymic stromal lymphopoietin (TSLP) in response to allergens (6) . The overexpression of the TSLP gene in airway epithelial cells has been shown to lead to asthma and TSLP has been suggested to play an important role in the initiation and maintenance of the allergic immune response (6,7). TSLP expression has been shown to (10) . It is cytoplasmically located and has been shown to play a multifunctional role in a variety of cellular responses (11, 12) . Recently, VDUP1 has been shown to play a role in vascular endothelial growth factor (VEGF)-and interleukin-1β-mediated signal transduction pathways (13) (14) (15) . However, little is known about the expression of VDUP1 in bronchial epithelial cells and its involvement in the activation of these cells.
In this study, to determine whether vitamin D enhances the expression of TSLP in airway epithelial cells and whether VDUP1 is involved in this process, 16-HBE cells were used. This SV40 large T antigen-transformed bronchial epithelial cell line is widely used for the investigation of the functional properties of bronchial epithelial cells (16, 17) . The results from this study demonstrate that TSLP expression can be manipulated by both inactive and active vitamin D via the VDUP1 pathway, therefore suggesting a novel mechanism by which vitamin D regulates immune function in the lungs.
Materials and methods
Cell culture, treatment and transfection. 16-HBE bronchial epithelial cells (Shanghai Fuxiang Biological Technology Co., Ltd., Shanghai, China) were cultured in MEM growth medium (Ginuo Biopharm Technology Co., Shanghai, China) supplemented with 10% fetal calf serum (Invitrogen Life Technologies, Carlsbad, CA, USA) and maintained at 37˚C in a humidified incubator in the presence of 5% CO 2 . Cells were cultured for at least 2 days (70-80% confluence) prior to stimulation with 25 D 3 and 1,25 D 3 (Sigma, St. Louis, MO, USA) for 6 h with or without pre-treatment with 1,000 nM itraconazole (Sigma) for 2 h (4).
The sequence of the VDUP1-targeting small interfering RNA (siRNA) was as follows: siRNA1 sense, 5'-GUCAGAGG CAAUCAUAUUATT-3' and antisense, 5'-UAAUAUGAUUG CCUCUGACTG-3'; siRNA2 sense, 5'-CUGUGAAGGUGA UGAUAUUTT-3' and antisense, 5'-AAUCUCAUCACCUUC ACAGTT-3'; siRNA3 sense, 5'-GAAACAAAUAUGAGUA CAATT-3' and antisense, 5'-UUGUACUCAUAUUUGUUU CCA-3'; and negative control (NC) sense, 5'-UUCUCCGAAC GUGUCACGUTT-3' and antisense, 5'-ACGUGACACGUU CGGAGAATT-3'. All siRNAs were purchased from Shanghai GenePharma Co., Ltd., Shanghai, China. The 16-HBE cells were seeded at a density of 1.2x10 5 cells/well in 12-well culture plates and cultured for 2 days. Cells that were 40-60% confluent, were transfected with 5 nM VDUP1-specific siRNA or control siRNA using the HiPerFect transfection reagent (Qiagen, Hilden, Germany) according to the manufacturer's instructions. The viability of the cells was determined by MTT assay. The transfected cells were cultured for an additional 48 h and then stimulated with 500 nM 25 D 3 and 50 nM 1,25 D 3 for 6 h. 
RNA isolation and real-time polymerase chain reaction (PCR). Gene expression was analyzed by real-time RT-PCR using SYBR
® Premix Ex Taq™ (Takara, Dalian, China) and the Mx3005p real-time qPCR system (Stratagene, Santa Clara, CA, USA). Total RNA was extracted with RNAisoPLUS (Takara) following the manufacturer's instructions and cDNA was synthesized from 500 ng of RNA using the PrimeScript™ RT kit. The qRT-PCR reaction mixture contained 1X SYBR Premix Ex Taq, 200 nM forward and reverse primers and 2 µl cDNA in a final volume of 25 µl. The primers (Invitrogen, Shanghai, China) used were: human TSLP (forward, 5'-GCCC AGGCTATTCGGAAAC-3' and reverse, 5'-GAAGCGACG CCACAATCC-3'), VDUP1 (forward, 5'-ACTCGTGTCAAAG CCGTTAGGA-3' and reverse, 5'-AGCTCAAAGCCGAACTT GTACTCA-3') and β-actin (forward, 5'-GTGGACATCCGC AAAGAC-3' and reverse, 5'-GAAAGGGTGTAACGC AACT-3'). The PCR cycling conditions were as follows: 95˚C for 15 sec, 58˚C for 15 sec and 72˚C for 15 sec for 40 cycles. The melting curve was made by increasing the temperature from 65 to 95˚C at a ramp rate of 2% for 20 min. The qRT-PCR samples were evaluated using a single predominant peak as a quality control. The cycle threshold (Ct) values were used to calculate the relative expression levels of the messenger RNA (mRNA). The expression levels of all genes were normalized to the expression of a reference gene (β-actin).
Western blot analysis. The cells were washed 3 times with phosphate-buffered saline (PBS) and disrupted in ice-cold lysis buffer (20 mM Tris, 20 mM β-glycerophosphate, 150 mM NaCl, 3 mM EDTA, 3 mM EGTA, 1 mM Na 3 VO 4 , 0.5% Nonidet P-40 and 1 mM dithiothreitol). The protein concentration of the lysates was determined using the Bradford protein assay (Nanjing KeyGen Biotech. Co., Ltd., Nanjing, China). Protein (40 µg/lane) was separated on a 10% SDS-polyacrylamide gel and transferred onto a PVDF membrane (Millipore, Billerica, MA, USA). The membrane was blocked with 5% skim milk in Tris-buffered saline with Tween-20 (TBST) (50 mM Tris-HCl, pH 7.5, 150 mM NaCl and 0.05% Tween-20) for 1 h at room temperature and then incubated overnight with rabbit antihuman VDUP1 polyclonal antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) 1:600 at 4˚C. The membrane was washed with TBST (3x15-min washes) and incubated in anti-rabbit IgG secondary antibody conjugated with horseradish peroxidase (Boster Biological Technology, Ltd., Wuhan, China) 1:5,000 for 1 h at room temperature. Protein signal was detected using the SuperECL system (Nanjing KeyGen Biotech. Co., Ltd.) and detected by radiography. The immunoreactive bands were visualized using a Kodak 2000M camera (Eastman Kodak Co., Rochester, NY, USA) according to the manufacturer's instructions. An anti-GAPDH goat polyclonal antibody (1:500; Santa Cruz Biotechnology, Inc.) was used to confirm equal loading.
TSLP enzyme-linked immunosorbent assay (ELISA)
. TSLP in culture supernatants were detected by ELISA (R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instructions and the data were normalized to the total protein amounts in the samples, as determined by Bradford assay (Bio-Rad, Hercules, CA, USA). The minimal detectable level of TSLP was 31.25 pg/ml.
Statistical analysis. Data are presented as the means ± SEM. Differences among multiple groups were assessed for statistical significance by one-way analysis of variance; Bonferroni's method was used for multiple comparisons. When 2 groups were being compared we used a one-or two-tailed Student's t-test depending on the hypothesis in question. A P-value <0.05 was considered to indicate a statistically significant difference.
Results

D 3 induces TSLP expression in 16-HBE cells.
A previous study demonstrated that respiratory epithelial cells have the enzymatic machinery required to activate vitamin D, which exerts profound effects on epithelial cells (4) . To determine whether inactive 25 D 3 affects TSLP expression in airway epithelial cells, we first investigated the effects of 25 D 3 on the viability of 16-HBE cells. We found no loss in cell viability when the 16-HBE cells were stimulated with various concentrations of 25 D 3 (50-1,000 nM) (Fig. 1) . Based on our concentration-response curve, TSLP mRNA levels significantly increased at concentrations of 100 nM and peaked at concentrations 500 nM 25 D 3 ( Fig. 2A) . Therefore, we used the concentration of 500 nM in the subsequent experiments. The time-response results revealed that TSLP mRNA ( VDUP1 silencing by RNAi. To determine the biological function of VDUP1, its expression was silenced by RNA interference. Three RNA duplexes (siRNA1, siRNA2 and siRNA3) directed against VDUP1 were synthesized (see Materials and methods). As shown in Fig. 4A and B, extracts prepared from the cells transfected with either the siRNA2 or siRNA3 duplex showed reduced VDUP1 levels. This effect was more pronounced with the use of siRNA3, wherein VDUP1 expression was <35% of the control (Fig. 4B ). siRNA1 and siRNA2 reduced VDUP1 expression to 40-80% of the control. Therefore, we selected VDUP1 siRNA3 in the subsequent experiments. 25 D 3 -induced TSLP production, we investigated whether VDUP1 is involved in this process. We used VDUP1 siRNA3 to suppress VDUP1 expression in the 16-HBE cells. The viability of the cells was >90% in the siRNA-transfected cells. We observed a significantly lower level of TSLP mRNA (Fig. 5A) and protein (Fig 5B) (Fig. 6B) . We then examined the effects of itraconazole on the induction of TSLP by 25 D 3 . The results revealed that in the presence of itraconazole (1,000 nM), there was a significantly lower production of TSLP mRNA (Fig. 6C) and protein (Fig. 6D) (Fig. 7A) . Based on the concentration-response curve, TSLP mRNA (Fig. 7B) and protein (Fig. 7C ) levels significantly increased at 0.1 nM, and peaked at concentrations of 50 nM 1,25 D 3 . The levels of TSLP mRNA (Fig. 7D) and protein (Fig. 7E) expression significantly increased at 2 h and peaked at 12 h in the cells exposed to 50 nM 1,25 D 3 . To determine the role of VDUP1 in this process, we examined the mRNA expression level of VDUP1 at the same time following treatment with 50 nM 1,25 D 3 for 6 h and VDUP1 was also manipulated via the siRNA-mediated silencing of VDUP1. The results revealed that VDUP1 mRNA (Fig. 7F ) expression was significantly upregulated in the 16-HBE cells treated with 50 nM 1,25 D 3 for 6 h when compared with the untreated cells. In comparison with the control siRNA-treated cells, following treatment with 50 nM 1,25 D 3 , we observed a significantly lower level of TSLP mRNA (Fig. 7G) and protein (Fig. 7H) in the cells in which VDUP1 was silenced. These results suggest that the VDUP1 pathway is involved in the 1,25 D 3 -induced TSLP expression in 16-HBE cells.
Silencing of VDUP1 decreases
Inhibition of 1α-hydroxylase exerts no effects on 1,25 D 3 -induced TSLP expression in 16-HBE cells.
To confirm the specificity of the TSLP production induced by 1,25 D 3 , we treated the cells with itraconazole, as well as 1,25 D 3 . We found that in the presence of itraconazole (1,000 nM), a similar induction of TSLP by 1,25 D 3 was obsevered ( Fig. 8A and B) . This further supports our primary hypothesis that 1α-hydroxylase converts inactive vitamin D to active vitamin D and induces TSLP expression in 16-HBE cells.
Discussion
In the present study, we investigated the effect of 25 circulating systemically is likely insufficient to promote optimal immunoregulatory effects in vivo (18) . Moreover, the commonly used concentration of 1,25 D 3 in vivo and in vitro that promotes optimal 1,25 D 3 -dependent effects in several cell types, ranges from 10 to 100 nM (4, 19, 20) . In the concentration-response curve of 1,25 D 3 , we observed that the induction of TSLP expression by 1,25 D 3 peaked at the concentration of 10-100 nM. Therefore, our data indicate that the airway epithelial cell production of active 1,25 D 3 from its inactive precursor is likely to be a crucial factor in the contribution of vitamin D to immune regulation in vivo.
Recently, emerging evidence suggests that vitamin D exerts a protective effect against asthma (2, 21, 22) . Other studies (6, 7, 23) have indicated that TSLP represents a master switch of allergic inflammation and have established a direct link between TSLP expression in keratinocytes and airway epithelial cells and the pathogenesis of atopic dermatitis and asthma, respectively. It seems that our results contradict those from the abovementioned studies; in fact, the correlation between vitamin D and asthma has been a matter of debate for several years (24) (25) (26) . A possible direct involvement of vitamin D signaling in atopy is supported by the observation that vitamin D receptor-null mutant mice fail to develop symptoms of experimental asthma. Li et al demonstrated that the topical induction of TSLP expression by 1,25 D 3 in mouse epidermal keratinocytes resulted in an atopic dermatitis-like syndrome (9) . On the other hand, in combination with the previously known pro-T helper type 2 cytokine function, certain studies have indicated that TSLP plays a role in host defense (27, 28) . Therefore, it is of interest to elucidate the role of the vitamin D-mediated production of TSLP in airway epithelial cells in asthma.
TSLP has been shown to be produced by airway epithelial cells (6, 29, 30) . However, the definite regulation of TSLP expression needs to be further clarified. TSLP expression has previously been shown to be regulated via the NF-κB signaling pathway in airway epithelial cells (30, 31) . Tumor necrosis factor-α and interleukin-1β-induced TSLP expression has been shown to be regulated via the mitogen-activated protein kinase pathway in human airway smooth muscle cells (32) . Our data demonstrated that the silencing of VDUP1 resulted in a significant reduction in 25 D 3 and 1,25 D 3 -induced TSLP expression. These data suggest a novel pathway of TSLP regulation in airway epithelial cells.
However, the mechanism underlying the VDUP1-mediated upregulation of TSLP expression in 16-HBE cells remains unclear. VDUP1 interacts with the antioxidant, thioredoxin, thereby inhibiting the reducing activity of thioredoxin and blocking the interactions of thioredoxin with other factors, such as apoptosis signal-regulating kinase (12) . This increases the vulnerability of cells to oxidative stress. In another study, Tang et al reported that reactive oxygen species mediate the release of TSLP by epithelial cells (33) . Thus, the possible underlying mechanism is that VDUP1 promotes oxidative stress, which induces TSLP secretion followed by an increase in reactive oxygen species production through the inhibition of thioredoxin activity.
Of note, previous studies have demonstrated that: ⅰ) vitamin D decreases the respiratory syncytial virus-mediated induction of the NF-κB-linked cytokine, interferon-β, and chemokine (C-X-C motif) ligand 10 in airway epithelial cells (34) ; and ⅱ) Geldmeyer-Hilt et al demonstrated that 1,25 D 3 impairs NF-κB activation in human naïve B cells (35) . VDUP1 has been shown to suppress tumor necrosis factor-α-induced NF-κB activation in hepatocarcinogenesis (15) . Therefore the correlation between vitamin D, VDUP1, NF-κB and TSLP under different circumstances requires further investigation.
There were obvious limitations to this study. First, although our data convincingly demonstrate that vitamin D metabolites increase TSLP expression, the biological consequences of such a regulation were not investigated. Second, the physiological relevance of our experiments was limited by the use of a transformed cell line; the results cannot necessarily be extrapolated to primary cells. Third, itraconazole is a broad spectrum inhibitor of cytochrome P450 enzymes, with activity against CYP24A as well as CYP27B1. The knockdown of CYP27B1 would provide more conclusive evidence that the pathway demonstrated was CYP27B1-dependent.
In conclusion, our data indicate that both inactive 25 D 3 and active 1,25 D 3 induce TSLP expression in 16-HBE cells, and that VDUP1-associated cell signaling is involved in this process. Further studies are required to determine the role of vitamin D and the mechanisms by which it modulates epithelial TSLP expression in airway diseases. 
